BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sabeti Aghabozorgi A, Moradi Sarabi M, Jafarzadeh-Esfehani R, Koochakkhani S, Hassanzadeh M, Kavousipour S, Eftekhar E. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World J Gastrointest Oncol 2020; 12(9): 942-956 [PMID: 33005290 DOI: 10.4251/wjgo.v12.i9.942]
URL: https://www.wjgnet.com/1948-9366/full/v12/i9/942.htm
Number Citing Articles
1
Cailan Li, Jianhui Xie, Jiahao Wang, Ying Cao, Min Pu, Qihai Gong, Qiang Lu. Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.969550
2
Chun-Chun Huang, Le-Qian Ying, Yan-Ping Chen, Min Ji, Lu Zhang, Lin Liu. Metachronous primary esophageal squamous cell carcinoma and duodenal adenocarcinoma: A case report and review of literatureWorld Journal of Gastrointestinal Surgery 2023; 15(11): 2627-2638 doi: 10.4240/wjgs.v15.i11.2627
3
Laura Grumetti, Rita Lombardi, Federica Iannelli, Biagio Pucci, Antonio Avallone, Elena Di Gennaro, Alfredo Budillon. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid TumorsCancers 2022; 14(3): 695 doi: 10.3390/cancers14030695
4
Saihong Yu, Zhuduo Li, Linglan Tu, Yiyi Pu, Dongmei Yan, Xiaoju Wang, Xiaoliang Zheng, Jie Yu. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axisJournal of Physiology and Biochemistry 2022; 78(3): 679 doi: 10.1007/s13105-022-00894-5
5
Seyed Hamid Moosavy, Shabnaz Koochakkhani, Mahdi Barazesh, Shiva Mohammadi, Khadijeh Ahmadi, Behnaz Rahnama Inchehsablagh, Soudabeh Kavousipour, Ebrahim Eftekhar, Pooneh Mokaram. In silico Analysis of Single Nucleotide Polymorphisms Associated with MicroRNA Regulating 5-fluorouracil Resistance in Colorectal CancerLetters in Drug Design & Discovery 2022; 19(2): 144 doi: 10.2174/1570180818666210930161618
6
Yang Gao, Chen Liu, Xiaoyun Xu, Yijing Wang, Yuanyuan Jiang. Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axisAnti-Cancer Drugs 2022; 33(6): 553 doi: 10.1097/CAD.0000000000001285
7
Austin A. Saugstad, Natasha Petry, Catherine Hajek. Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic RelationshipsFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.857120
8
Shiekhah Alzahrani, Huda Al Doghaither, Ayat Al‑ghafari, Peter Pushparaj. 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)Oncology Reports 2023; 50(4) doi: 10.3892/or.2023.8612
9
Leila Mousazadeh, Behzad Mousazadeh, Jamshid Motaei, Faezeh Abbasi, Reza Jafarzadeh Esfehani. Preclinical and Clinical Aspects of using Tazemetostate in Human CancersCurrent Pharmaceutical Design 2022; 28(16): 1329 doi: 10.2174/1381612828666220408121514
10
Paulína Pidíková, Iveta Herichová. miRNA Clusters with Up-Regulated Expression in Colorectal CancerCancers 2021; 13(12): 2979 doi: 10.3390/cancers13122979
11
Teppei Miyakawa, Hidetaka Kawamura, Michitaka Honda, Yoshinao Takano, Shunji Kinuta, Takahiro Kamiga, Shigeru Yamazaki, Atsushi Muto, Satoru Shiraso, Naoyuki Yamashita, Toshiyasu Iwao, Koji Kono, Shinichi Konno, Wen-Chi Chou. Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort studyPLOS ONE 2022; 17(3): e0264652 doi: 10.1371/journal.pone.0264652